Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:
Brexit Regulation Europe

EMA Set For More Staff Losses & Activity Cuts Next Year

  • News

Executive Summary

The latest EMA management board meeting heard an update on the situation regarding Brexit-related staff losses and recruitment, and was told that an additional set of temporary suspensions or reductions in its activities might be necessary from the beginning of 2019.
Table

View full table

Advertisement

Related Content

Pink Sheet
EU Drug Filings To Fall Slightly In 2019, But Scientific Advice On The Up
Pink Sheet
Brexit: Number Of Drugs At Risk Of Shortage Cut From 108 to 39
Pink Sheet
EMA’s Request For Extra Staff Rebuffed As Losses ‘Worsen Dramatically’
Pink Sheet
Brexit Bites EMA: Huge Staff Losses Freeze Many Projects

Topics

Advertisement
Tags:
Brexit Regulation Europe
UsernamePublicRestriction

Register

PS124404

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By